From: Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India
Clinical features | Severe malaria (n = 58) (%) | Uncomplicated malaria (n = 119) (%) | Total number of patients (n = 177) (%) | Chi-square (df) | P |
---|---|---|---|---|---|
Hepatosplenomegaly | 49 (84.5) | 5 (4.2) | 54 (30.5) | 109.9 (1) |  < 0.0001* |
Headache | 51 (87.9) | 9 (7.6) | 30 (17.0) | 108.8 (1) |  < 0.0001* |
Pallor | 36 (62.1) | 5 (4.2) | 41 (23.2) | 70.2 (1) |  < 0.0001* |
Seizures (> 2 episodes in 24 h) | 8 (13.8) | 0 (0.0) | 8 (4.5) | 14.1 (1) | 0.0002* |
Altered sensorium | 7 (12.1) | 0 (0.0) | 7 (3.9) | 11.7 (1) | 0.0006* |
Vomiting | 12 (20.7) | 4 (3.4) | 16 (9.03) | 12.2 (1) | 0.0005* |
Jaundice (Bilirubin > 2 mg%) | 15 (25.9) | 0 (0.0) | 15 (8.47) | 30.3 (1) |  < 0.0001* |
Epistaxis | 8 (13.8) | 0 (0.0) | 8 (4.60) | 14.1 (1) | 0.0002* |
Haematuria | 3 (5.2) | 0 (0.0) | 3 (1.70) | 3.5 (1) | 0.0599 |
Hematemesis | 2 (3.4) | 0 (0.0) | 2 (1.10) | 1.64 (1) | 0.2003 |
Melena | 2 (3.4) | 0 (0.0) | 2 (1.10) | 1.64 (1) | 0.2003 |
Hypovolemic shock (SBP < 80 mmHg) | 4 (6.8) | 0 (0.0) | 4 (2.3) | 5.5 (1) | 0.0184* |
Breathlessness | 14 (24.1) | 1 (0.8) | 15 (8.47) | 24.3 (1) |  < 0.0001* |
Pulmonary oedema | 8 (13.8) | 0 (0.0) | 8 (4.60) | 14.1 (1) | 0.0002* |
Rash | 4 (6.8) | 0 (0.0) | 4 (2.26) | 5.5 (1) | 0.0184* |
Decreased urine output | 7 (12.1) | 0 (0.0) | 7 (3.95) | 11.7 (1) | 0.0006* |